Oral Bedtime Melatonin in Critically Ill Patients

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

February 1, 2026

Study Completion Date

April 1, 2026

Conditions

Septic ShockStroke HemorrhagicStrokes ThromboticCardiac Arrest

Interventions

DRUG

Oral Bedtime Melatonin

100 mg oral suspension or capsule given at bedtime

DRUG

Placebo suspension or capsule

Indistinguishable suspension or capsule

All Listed Sponsors

collaborator

Universidad Complutense de Madrid

OTHER

lead

Hospital San Carlos, Madrid

OTHER